Scott L Silliman, MD

Treats Adults

Neurologist, Vascular Neurologist

4.9 /5 425 ratings

(904) 383-1022

Request appointment online

Provider profile Menu

Research at a glance

Top areas of exploration

Stroke , 21 publications
Cerebral Hemorrhage , 16 publications
Genetic Predisposition to Disease , 12 publications
Brain Ischemia , 11 publications

Research activity

62 publications

3,916 citations

Why is this important?

Active clinical trials

ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke

Investigators: Benjamin T Alwood, Scott L Silliman
Status: Accepting Candidates
Ages: 18 Years - 90 Years
Sexes: All

ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke

Investigators: Benjamin T Alwood, Scott L Silliman
Status: Accepting Candidates
Ages: 18 Years - 90 Years
Sexes: All

My publications

62 publications

2024

Symptomatic idiopathic intracranial hypertension triggered by Ramadan intermittent fasting: a case report.

Nutritional neuroscience

鈥�

2024

Endovascular Mechanical Thrombectomy for Ischemic Stroke Treatment in the Setting of Aortic Dissection: Case Report.

Case reports in neurology

鈥�

2021

Rare Missense Functional Variants at COL4A1 and COL4A2 in Sporadic Intracerebral Hemorrhage.

Neurology

鈥�

2020

Exercise-based swallowing intervention (McNeill Dysphagia Therapy) with adjunctive NMES to treat dysphagia post-stroke: A double-blind placebo-controlled trial.

Journal of oral rehabilitation

鈥�

2019

Genome-wide association study of cerebral small vessel disease reveals established and novel loci.

Brain : a journal of neurology

鈥�

萝莉社